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Introduction 
 
 With the vicissitude of the capital markets, investors continually seek new and 
innovative techniques that will identify securities that outperform the market.  In addition 
to the usual fundamental and technical analysis, the international markets may provide 
enhanced profit potential.  Investors may purchase securities of foreign companies to gain 
greater diversity and new investment opportunities.   
 
To eliminate much of the difficulties of purchasing foreign stock directly, 
individuals and businesses may purchase financial instruments known as American 
Depository Receipts (ADRs) which are traded like domestic shares of stock on the over-
the-counter market, American Stock Exchange, and the New York Stock Exchange.  
American Depository Receipts are certificates created by large U.S. banks that represent 
ownership of a certain number of shares of stock of a foreign company denominated in 
dollars.   The bank holds the original foreign stock in a trust and allows the owner of the 
ADR to receive dividends in U.S. dollars.  The market value of the ADRs change with 
the market value of the underlying foreign stock held in trust (Besley and Brigham, 
1999).  About 1700 ADRs are now available in the United States (Brigham and Ehrhardt, 
2005).   
 
Although ADRs have gained popularity since J.P. Morgan introduced them in 
1927, ADRs include unique differences in risk.  First, the underlying firms have a high 
degree of asymmetric information not easily obtained by domestic investors.  Legal 
standards in foreign countries may not demand a comparable level of honesty or financial 
disclosure expected from American firms.  Information that is disclosed may not be 
written in English.  Second, the price movements of ADRs reflect not only the economy 
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of the foreign country, but also the currency fluctuations (Liang and Mougoue, 1996).  
Third, voting rights do not pass to the owners of ADRs therefore eliminating control of 
the company. 
 
 On the other hand, ADRs provide the advantages of no brokerage mandated 
trading minimums and no need to convert dollars into foreign current to buy the 
securities.  Furthermore, companies offering ADRs tend to be large, well established 
companies which may reduce the investment risk.  Traded in a larger and more efficient 
market, the shares tend to have greater liquidity.  Jiang (1998) and Officer and 
Hoffmeister (1988) suggest these advantages are important to ADR investors who seek 
international diversification.  Recently ADRs have been especially helpful in providing 
funding for acquisitions and multi-billion dollar buy-outs of foreign companies such as 
the British Petroleum acquisition of Amoco Corporation (Drexhage, 1998, and Shearer, 
2001).       
 
 Studies tend to show mixed results on the performance of ADRs.  Callaghan, 
Kleiman and Sahu (1999) suggests ADRs yield significantly positive market-adjusted 
returns in both the short-term and long-term investment horizons with first year 
cumulative abnormal returns of 19.6% and that ADRs from emerging markets (34.37% 
first year cumulative abnormal return) outperform those from developed countries.  
Sundaram and Logue (1996) likewise find significant positive abnormal returns in ADR 
early trading.  On the other hand, Foerster and Karolyi (2000) find ADRs under-perform 
comparable firms by 8%-15% during the first three years following the date of issue.  
Ritter (1984, and 1991) concludes that global equity offerings under-perform the market 
in the long run.  Martell, Rodriguez and Webb (1999) find that price changes of the 
underlying shares for ADRs from emerging markets are not significant while Jayaraman, 
Shastri and Tandon (1993) find the variances of the underlying shares from developed 
markets to be significantly higher after listing the ADRs.  This study attempts to address 
the conundrum of investing in foreign financial companies. 
   
The Problem 
 
 The problem of this study is to determine whether foreign finance industry 
equities generally outperform the market over a three-year period and to determine 
whether foreign financial institution equities from developed markets differ from those of 
emerging markets.  A secondary part of the problem is to determine whether initial public 
offerings (IPOs) differ from seasoned equity offerings (SEOs) for foreign financial 
institutions. 
 
Data 
 
 This study examines the long-run abnormal returns from a sample of 58 foreign 
financial institution equities traded on the New York Stock Exchange from January 1, 
1987 through September 30, 2000.  Of the 58 ADRs, 16 are from emerging markets and 
42 are from developed markets; 31 issues are IPOs and 27 are SEOs.  Table 1 identifies 
the countries and the number of stock issues from each.  Twenty-two countries are 
represented in the sample.   
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Methodology 
 
 Standard IPO event study methodology is followed to compute and test the 
abnormal returns of the ADR portfolios. The ADR sample includes only firms listed on 
the New York Stock Exchange. Returns are examined over a 36-month period following 
the date of issue. The S & P 500 index is used as a proxy for the market return.  Monthly 
abnormal returns are computed by subtracting each monthly holding period return from 
that of the S & P 500 index.  Security price and S & P 500 return data were obtained from 
Commodity Systems, Inc.    
 
 A limitation of the study is that no adjustments are made for economic changes 
occurring in the sample countries during the investigation period.  The focus of the paper 
is to determine the results that a typical investor would reap by purchasing in a portfolio 
of financial institution equities from a diversified group of countries during a specified 
holding period.  Including the random events of the countries, perhaps leads to findings 
that investors generally encounter in the real world.  
 
  Equations 1 through 3 describe the process for computing abnormal returns and 
cumulative abnormal returns for statistical testing.  The abnormal return for each security 
i on month t (arit) is computed as the difference between the return of the security on 
month t (rit ) and the return of the market on month t (rmt) as shown in equation 1 below. 
 
                                                                    rrar mtitit                                                                      (1) 
Equation 2 computes the average abnormal return for the sample for month t 
(ARt) as the simple average of the sum of the abnormal returns of each of the n securities 
during month t.  
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Cumulative abnormal returns as of month s are computed as the summation of the 
average abnormal returns starting at month 1 until month s in Equation 3. 
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Monthly average abnormal returns and the cumulative abnormal returns are tested 
to determine significance using a Z-score.  The respective p-values for these tests are 
given in the findings.  A p-value of .10 or less indicates the abnormal return or 
cumulative abnormal return is significantly different from 0. 
 
Findings 
 
 Findings suggest that over the 36-month period, cumulative abnormal returns for 
the entire sample of 58 foreign finance industry equities tend to slightly outperform the S 
& P 500 with a cumulative abnormal gain of 4.32 percent.  However, none of the 
cumulative abnormal returns during the 3-year period are significant.  Table 2 shows the 
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month by month abnormal returns, the cumulative abnormal returns, and the respective P-
values. After the first month of trading the data show a –0.47 percent lower return than 
the S & P 500 market return.  During 14 of the first 16 months, the ADRs performed 
worse than the market with negative cumulative abnormal returns as low as –3.44 
percent.  Positive cumulative returns occur primarily during the last 20 months.  This 
leads to the question of whether a difference exists between ADRs from firms 
headquartered in emerging markets and those from developed markets. 
 
 Table 2, in the center and right columns, show the abnormal and cumulative 
abnormal returns by month for the finance industry ADRs from emerging markets and 
developed markets.  Cumulative abnormal returns from emerging markets are 
consistently negative for each of the 36-months which dropped as low as –24.16 percent 
below the performance of the market.  Of the 36 months, 7 months of the emerging 
market ADRs show significant under-performance.  On the other hand, ADRs from 
developed markets are positive (except for month 11) and reach cumulative abnormal 
returns as high as 16.96 percent by the 35
th
 month.  The 3-year period ended with a 
significant 15.17 gain.  Twenty-one months of the 36 produce positive cumulative 
abnormal returns that are significant.  Further investigation into whether initial public 
offerings differ from seasoned equity offerings may also be helpful for investors of 
foreign equities. 
 
 Although the sample of 58 issues exhibit mixed results that range from a high 
cumulative return of 8.05% to a low cumulative return of –3.44% with a final 36-month 
cumulative gain of merely 4.32%, Table 3 provides an interesting breakdown of ADR 
performance by IPOs and SEOs.  The data show a clear and distinct difference between 
the performance of initial public offerings and seasoned equity offerings.  The New York 
Stock Exchange considers a foreign firm’s first equity issue in the United States an initial 
public offering (IPO).  Foreign firms with shares already trading in the United States that 
issue ADRs are considered seasoned equity offerings (SEOs).  The IPO cumulative 
abnormal returns are consistently negative throughout the 3-year period and finish with a 
–9.94% loss.  Four months of the negative cumulative returns are significant.  In contrast, 
the SEOs ended the 3-year period with cumulative gains of 20.69%.  The first month, the 
18
th
, 19
th
, 20
th
 month,
 
and the last year produce gains that are significant.    
 
Summary and Conclusions 
 
 Overall, the sample of 58 foreign finance industry ADRs exhibit only mixed 
results with no significant cumulative abnormal returns.  During the first 12 months the 
ADRs perform poorly relative to the S & P 500 index producing a -2.46% cumulative 
abnormal return.  Slight insignificant gains occur in the final 24-months ending with a 
modest 4.32% 3-year cumulative abnormal return.  These findings are in sharp contrast to 
those of Callaghan, Kleiman, and Sahu (Winter, 2000) who examined 66 ADRs from 18 
countries that traded on the NYSE.  The authors report cumulative abnormal returns of 
19.6% for the first year.   On the other hand, Foerster and Karolyi (2000) and Ritter 
(1991) discover that ADRs under-perform the market during the 3-year period from date 
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of issue.  The financial institutions industry tends to perform in the middle of the 
extremes found in former studies that are based on multi-industry portfolios.     
 
A closer look at the foreign finance industry ADRs reveals that equities from 
developed countries tend to out-perform those from emerging markets.  Furthermore, 
seasoned equity offerings out-performed the initial public offerings.  These findings are 
contrary to other studies that show positive abnormal returns for unseasoned initial public 
offerings (Ritter, 1984, McDonald and Fisher, 1972, Martell, Rodriguez and Webb, 1999, 
Jayaraman, Shastri and Tandon, 1993, and Dawson, 1987).  On the other hand, the 
findings are consistent with studies by Ritter (1991), Brav and Gompers (1997), Ben 
Naceur (2000), Aggarwal, Leal and Herandez (1993), Levis (1993), and Huang (1999).  
 
This study, however, tends to suggest that the nature of the financial industry 
itself with firms such as insurance companies, banks, and financial services companies 
are unique businesses that perform best in developed markets.  Investors perhaps try to 
minimize their risk by purchasing finance industry ADRs that are seasoned rather than 
new and unproven issues. Because of the apparent asymmetric information between 
investors in the United States and foreign companies, the results tend to provide further 
evidence that a completely efficient market does not exist in the international markets.      
 
Overall, the implications are that investors must be selective in choosing their 
foreign equity portfolio. This study shows that financial industry ADRs that are seasoned 
equity offerings and those that are from developed markets generally tend to out-perform 
the S & P 500 index while IPOs and equities from emerging markets typically under-
perform the market. 
 
 
Table 1 
Survey Sample Of Foreign Finance Industry Stocks Issued From January 1987 – 
September 2000 by Country 
Argentina:  3 Issues  Italy:  1 Issue 
Australia:  3 Issues  Japan:  1 Issue 
Bermuda:  8 Issues  Luxembourg:  1 Issue 
Brazil:  1 Issue  Netherlands:  3 Issues 
Canada:  10 Issues  Panama:  1 Issue 
Chile:  6 Issues  Peru:  1 Issue 
Columbia:  1 Issue  Portugal:  1 Issue 
France:  2 Issues  Puerto Rico:  3 Issues 
Greece:  1 Issue  Spain:  2 Issues 
India:  1 Issue  Switzerland:  1 Issue 
Ireland:  2 Issues  United Kingdom:  5 Issues 
Total:  58 Issues from 22 Countries   
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Table 2 
Long-term Return Performance by Month for Finance Industry ADRs Broken Down by Developed and Emerging Market 
Issues (January 1987 –September 2000)a 
 
 
 
Entire Finance ADR Sample 
(58 Observations) 
 Finance ADRs From Emerging Markets  
(16 Observations) 
 Finance ADRs From Developed Markets 
(42 Observations) 
Month AR P-value CAR P-value  AR P-value CAR P-value  AR P-value CAR P-value 
+  1 -0.47% 0.37 -0.47% 0.37  -2.21% 0.30 -2.21% 0.30  0.19% 0.44 0.19% 0.44 
+  2 0.47% 0.36 0.00% 0.50  -2.05% 0.25 -4.25% 0.20  1.44% 0.15 1.62% 0.19 
+  3 -0.50% 0.67 -0.50% 0.41  -6.82% 0.00 -11.07% 0.03  1.91% 0.04 3.53% 0.05 
+  4 -2.17% 0.02 -2.67% 0.14  -4.82% 0.03 -15.89% 0.01  -1.16% 0.14 2.37% 0.16 
+  5 2.88% 0.04 0.21% 0.47  7.89% 0.05 -8.00% 0.16  0.97% 0.22 3.34% 0.11 
+  6 -0.81% 0.26 -0.60% 0.43  -2.30% 0.25 -10.30% 0.12  -0.25% 0.42 3.09% 0.15 
+  7 -0.40% 0.37 -1.00% 0.39  1.93% 0.28 -8.37% 0.19  -1.28% 0.11 1.81% 0.29 
+  8 0.29% 0.40 -0.71% 0.42  1.91% 0.21 -6.46% 0.25  -0.33% 0.40 1.48% 0.33 
+  9 0.36% 0.38 -0.35% 0.46  2.65% 0.12 -3.81% 0.35  -0.52% 0.34 0.96% 0.40 
+10 -1.02% 0.13 -1.38% 0.36  -2.27% 0.17 -6.08% 0.28  -0.55% 0.27 0.41% 0.46 
+11 -2.06% 0.06 -3.44% 0.20  -5.97% 0.05 -12.06% 0.14  -0.57% 0.30 -0.15% 0.48 
+12 0.97% 0.22 -2.46% 0.29  -0.26% 0.47 -12.32% 0.15  1.45% 0.06 1.29% 0.37 
+13 0.40% 0.39 -2.07% 0.33  -1.30% 0.34 -13.62% 0.13  1.04% 0.24 2.34% 0.29 
+14 1.66% 0.07 -0.41% 0.47  -0.58% 0.41 -14.20% 0.12  2.52% 0.02 4.85% 0.14 
+15 -0.96% 0.28 -1.37% 0.39  -8.50% 0.02 -22.71% 0.04  1.91% 0.10 6.76% 0.08 
+16 -0.51% 0.36 -1.88% 0.36  0.84% 0.43 -21.86% 0.06  -1.02% 0.17 5.74% 0.12 
+17 2.85% 0.01 0.97% 0.43  6.72% 0.02 -15.14% 0.14  1.37% 0.13 7.11% 0.08 
+18 -0.72% 0.24 0.25% 0.48  -2.97% 0.12 -18.11% 0.11  0.13% 0.45 7.24% 0.08 
+19 0.05% 0.49 0.30% 0.48  -1.41% 0.36 -19.52% 0.10  0.61% 0.31 7.85% 0.07 
+20 1.04% 0.26 1.34% 0.41  1.97% 0.36 -17.55% 0.13  0.69% 0.26 8.53% 0.06 
+21 -1.66% 0.08 -0.32% 0.48  -5.67% 0.04 -23.22% 0.08  -0.13% 0.45 8.40% 0.06 
+22 1.21% 0.16 0.89% 0.44  1.57% 0.31 -21.65% 0.09  1.07% 0.20 9.47% 0.04 
+23 -0.45% 0.35 0.44% 0.47  5.00% 0.05 -16.65% 0.16  -2.52% 0.01 6.95% 0.11 
+24 1.88% 0.05 2.32% 0.36  2.52% 0.16 -14.13% 0.20  1.64% 0.09 8.59% 0.07 
+25 1.13% 0.15 3.45% 0.30  2.53% 0.19 -11.60% 0.25  0.59% 0.28 9.18% 0.06 
+26 0.53% 0.34 3.98% 0.27  0.11% 0.49 -11.49% 0.26  0.69% 0.30 9.87% 0.05 
+27 -1.51% 0.13 2.47% 0.36  -2.95% 0.09 -14.44% 0.21  -0.96% 0.28 8.91% 0.08 
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+28 1.06% 0.23 3.53% 0.30  -0.09% 0.49 -14.53% 0.21  1.50% 0.17 10.41% 0.05 
+29 -0.39% 0.36 3.14% 0.32  0.35% 0.44 -14.17% 0.22  -0.67% 0.30 9.74% 0.07 
+30 0.63% 0.32 3.77% 0.30  0.30% 0.47 -13.87% 0.23  0.75% 0.28 10.49% 0.06 
+31 0.63% 0.31 4.40% 0.27  0.55% 0.44 -13.32% 0.24  0.66% 0.29 11.16% 0.05 
+32 0.32% 0.37 4.72% 0.26  0.15% 0.48 -13.17% 0.24  0.38% 0.35 11.54% 0.05 
+33 1.78% 0.18 6.50% 0.19  0.17% 0.48 -13.00% 0.25  2.40% 0.16 13.94% 0.03 
+34 1.55% 0.17 8.05% 0.15  -1.30% 0.38 -14.30% 0.23  2.63% 0.05 16.57% 0.01 
+35 -2.37% 0.04 5.68% 0.23  -9.62% 0.00 -23.92% 0.11  0.39% 0.38 16.96% 0.01 
+36 -1.36% 0.13 4.32% 0.29  -0.24% 0.44 -24.16% 0.11  -1.79% 0.12 15.17% 0.03 
  
Note:  P-values in bold italics represent returns significant at the .10 level. 
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Table 3 
Long-term Return Performance by Month for Finance Industry ADRs Broken 
Down by Initial Public Offerings and Seasoned Equity Offerings (January 1987 
– September 2000)a 
 
 
 
Entire Finance ADR Sample 
(58 Observations) 
 Finance Industy ADR IPOs  
(31 Observations) 
 Finance Industy ADR SEOs 
(27 Observations) 
Month AR P-value CAR P-value  AR P-value CAR P-value  AR P-value CAR P-value 
+  1 -0.47% 0.37 -0.47% 0.37  -3.10% 0.08 -3.10% 0.08  2.54% 0.06 2.54% 0.06 
+  2 0.47% 0.36 0.00% 0.50  1.97% 0.16 -1.13% 0.35  -1.24% 0.23 1.30% 0.29 
+  3 -0.50% 0.67 -0.50% 0.41  -2.48% 0.07 -3.61% 0.15  1.77% 0.11 3.07% 0.14 
+  4 -2.17% 0.02 -2.67% 0.14  -1.97% 0.09 -5.58% 0.07  -2.40% 0.07 0.67% 0.42 
+  5 2.88% 0.04 0.21% 0.47  2.43% 0.19 -3.14% 0.25  3.39% 0.02 4.06% 0.13 
+  6 -0.81% 0.26 -0.60% 0.43  0.16% 0.47 -2.99% 0.28  -1.93% 0.11 2.13% 0.30 
+  7 -0.40% 0.37 -1.00% 0.39  1.43% 0.23 -1.56% 0.39  -2.49% 0.02 -0.36% 0.47 
+  8 0.29% 0.40 -0.71% 0.42  -0.56% 0.38 -2.12% 0.35  1.27% 0.20 0.91% 0.42 
+  9 0.36% 0.38 -0.35% 0.46  0.44% 0.39 -1.69% 0.39  0.26% 0.44 1.18% 0.40 
+10 -1.02% 0.13 -1.38% 0.36  -2.40% 0.01 -4.09% 0.25  0.55% 0.36 1.73% 0.36 
+11 -2.06% 0.06 -3.44% 0.20  -4.31% 0.00 -8.40% 0.09  0.53% 0.39 2.26% 0.34 
+12 0.97% 0.22 -2.46% 0.29  0.66% 0.38 -7.74% 0.12  1.34% 0.16 3.60% 0.26 
+13 0.40% 0.39 -2.07% 0.33  0.03% 0.49 -7.72% 0.13  0.82% 0.35 4.42% 0.22 
+14 1.66% 0.07 -0.41% 0.47  1.57% 0.16 -6.15% 0.19  1.76% 0.14 6.19% 0.15 
+15 -0.96% 0.28 -1.37% 0.39  -2.17% 0.20 -8.32% 0.13  0.43% 0.41 6.62% 0.15 
+16 -0.51% 0.36 -1.88% 0.36  -1.52% 0.24 -9.84% 0.10  0.65% 0.36 7.27% 0.14 
+17 2.85% 0.01 0.97% 0.43  4.75% 0.01 -5.09% 0.26  0.66% 0.32 7.93% 0.12 
+18 -0.72% 0.24 0.25% 0.48  -2.21% 0.07 -7.30% 0.19  0.98% 0.24 8.92% 0.10 
+19 0.05% 0.49 0.30% 0.48  -1.19% 0.30 -8.50% 0.16  1.48% 0.15 10.40% 0.07 
+20 1.04% 0.26 1.34% 0.41  1.19% 0.33 -7.31% 0.21  0.87% 0.31 11.27% 0.06 
+21 -1.66% 0.08 -0.32% 0.48  -0.95% 0.24 -8.26% 0.18  -2.47% 0.12 8.80% 0.12 
+22 1.21% 0.16 0.89% 0.44  1.98% 0.17 -6.28% 0.25  0.32% 0.39 9.12% 0.12 
+23 -0.45% 0.35 0.44% 0.47  1.96% 0.14 -4.32% 0.32  -3.21% 0.01 5.91% 0.22 
+24 1.88% 0.05 2.32% 0.36  0.22% 0.44 -4.10% 0.33  3.80% 0.01 9.70% 0.11 
+25 1.13% 0.15 3.45% 0.30  1.49% 0.19 -2.62% 0.39  0.71% 0.29 10.42% 0.10 
+26 0.53% 0.34 3.98% 0.27  -0.77% 0.34 -3.39% 0.37  2.02% 0.11 12.43% 0.06 
+27 -1.51% 0.13 2.47% 0.36  -3.45% 0.03 -6.84% 0.25  0.72% 0.36 13.16% 0.06 
+28 1.06% 0.23 3.53% 0.30  1.78% 0.23 -5.06% 0.31  0.24% 0.43 13.39% 0.06 
+29 -0.39% 0.36 3.14% 0.32  -1.92% 0.11 -6.98% 0.25  1.37% 0.19 14.76% 0.04 
+30 0.63% 0.32 3.77% 0.30  0.83% 0.36 -6.14% 0.28  0.39% 0.39 15.16% 0.04 
+31 0.63% 0.31 4.40% 0.27  1.23% 0.29 -4.92% 0.33  -0.05% 0.48 15.10% 0.04 
+32 0.32% 0.37 4.72% 0.26  -0.67% 0.32 -5.59% 0.31  1.45% 0.12 16.55% 0.03 
+33 1.78% 0.18 6.50% 0.19  0.57% 0.37 -5.02% 0.33  3.18% 0.20 19.73% 0.02 
+34 1.55% 0.17 8.05% 0.15  0.50% 0.41 -4.52% 0.35  2.75% 0.13 22.49% 0.01 
+35 -2.37% 0.04 5.68% 0.23  -3.99% 0.01 -8.51% 0.23  -0.51% 0.40 21.98% 0.02 
+36 -1.36% 0.13 4.32% 0.29  -1.43% 0.12 -9.94% 0.19  -1.29% 0.28 20.69% 0.02 
  
Note:  P-values in bold italics represent returns significant at the .10 level. 
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